/PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Medical Officer Thomas Heineman, M.D., Ph.D., will participate in.
SAN DIEGO and TORONTO, April 10, 2023 Aptose Biosciences Inc. , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic. | April 10, 2023
SAN DIEGO and CALGARY, AB, March 28, 2023 /PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Dr. Matt Coffey, President and Chief Executive Officer, will
Aptose Biosciences to Participate in Cantor s The Future of Oncology Virtual Symposium streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.